Protocol Modification of Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome Study
Clin Appl Thromb Hemost
.
2018 Jan;24(1):192.
doi: 10.1177/1076029617729214.
Epub 2017 Sep 12.
Authors
Scott C Woller
1
,
Scott M Stevens
1
,
David A Kaplan
2
,
Matthew T Rondina
2
Affiliations
1
1 Intermountain Medical Center, Murray, UT, USA.
2
2 Internal Medicine, University of Utah, Salt Lake City, UT, USA.
PMID:
28893087
PMCID:
PMC6714642
DOI:
10.1177/1076029617729214
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Antiphospholipid
Antiphospholipid Syndrome*
Humans
Pyrazoles
Pyridones
Secondary Prevention*
Thrombosis
Substances
Antibodies, Antiphospholipid
Pyrazoles
Pyridones
apixaban